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Introduction The rapid translation of preclinical cell-based therapy to restore dam-
aged myocardium has raised questions concerning the best cell type as well as the best 
delivery route, and the best time of cell injection into the myocardium. Intramyocardial 
injection of stem cells is by far the most-used delivery technique in preclinical studies. 
We have recently demonstrated that c-Kit+ cardiac progenitor cells are able to organize 
themselves into a tissue-like cell mass in three-dimensional cultures, and with the help 
of an OPLA scaffold, many cells can create an organized elementary myocardium.
Hypothesis We designed random porosity and oriented poly-lactic acid and fibri-
noin scaffolds to be used as three-dimensional systems to favour differentiation of car-
diac progenitor cells. We tested them in vitro and in vivo to study their potentiality as 
surgical devices in cardiology.
Methods For the synthesis of PDLLA scaffolds, the Poly (D,L lactic acid) (RE-
SOMER® 207, MW = 252 kDa) polimer were used (6.7%) in Dicloromethane/Dimetil-
formamide (DCM/DMF) 70/30 (v/v). The three-dimensional structure was obtained by 
salt-leaching, using NaCl crystals as porosity agent (NaCl < 224 µm and <150 µm). For 
the synthesis of fibrinoin scaffolds, degummed silk fibres were dried and dissolved into 
9.3 m LiBr water solution (20% w/v) at 65°C for 3h. Scaffolds with different porosities, 
pore size, and properties were made by freeze-drying and salt-leaching. Scaffolds em-
bedded with collagen I and cardiac progenitor cells were implanted in the subcutaneous 
dorsal region of athymic Nude-Foxn1nu mice.
Results Cardiac progenitor cells differentiated into cardiomyocytes in vitro into 
PDLLA scaffolds in a M-199 medium supplemented with 20% FBS within 21 days. A 
less extent of differentiation has been obtained in the dorsal subcutaneous region, and a 
foreign body reaction has been recorded.
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